AG
IART icon

Algert Global’s Integra LifeSciences IART Stock Holding History

Algert Global’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-49,197
Closed -$1.12M – 1250
2024
Q4 		$1.12M Buy
49,197
+31,317
+175% +$684K 0.03% 756
2024
Q3 		$325K Sell
17,880
-27,135
-60% -$629K 0.01% 979
2024
Q2 		$1.31M Buy
+45,015
New +$1.34M 0.04% 606
2024
Q1 		– Sell
-47,350
Closed -$2.06M – 1161
2023
Q4 		$2.06M Hold
47,350
– – 0.08% 406
2023
Q3 		$1.81M Buy
+47,350
New +$1.99M 0.09% 393
2023
Q1 		– Sell
-23,374
Closed -$1.31M – 1212
2022
Q4 		$1.31M Sell
23,374
-11,990
-34% -$610K 0.07% 457
2022
Q3 		$1.5M Buy
+35,364
New +$1.81M 0.09% 382

Other funds holding IART

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Algert Global's IART Position: Q1 2025 in Review

Algert Global sold out of Integra LifeSciences (IART) in Q1 2025, closing a stake of 49,197 shares — an estimated $1.12M sold.

Algert Global first reported a position in IART in Q3 2022 and held it in 7 quarters. The position peaked at $2.06M in Q4 2023. 219 funds tracked by Wall St. Rank hold IART as of Q1 2025.

  • Algert Global reported no remaining Integra LifeSciences position as of Q1 2025 after selling out during the quarter.
  • Algert Global sold 49,197 Integra LifeSciences shares in Q1 2025, an estimated $1.12M.
  • Algert Global first reported a position in Integra LifeSciences in Q3 2022 and held it in 7 quarters.
  • Algert Global's Integra LifeSciences position peaked at $2.06M in Q4 2023.
  • 219 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2025.

Based on Algert Global's 13F filing for Q1 2025, filed 13 May 2025.